Artelo Biosciences Inc. (ARTL)
NASDAQ: ARTL
· Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT
-0.30% (1D)
| Bid | 9.2 |
| Market Cap | 7.09M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.55M |
| EPS (ttm) | -18.93 |
| PE Ratio (ttm) | -0.53 |
| Forward PE | -1.08 |
| Analyst | Buy |
| Ask | 11 |
| Volume | 17,884 |
| Avg. Volume (20D) | 671,615 |
| Open | 10.04 |
| Previous Close | 10.09 |
| Day's Range | 9.90 - 10.40 |
| 52-Week Range | 4.92 - 28.60 |
| Beta | 1.36 |
About ARTL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARTL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-14%
ARTL stock has given up its prior gain. Artelo Bio...
Unlock content with
Pro Subscription
2 weeks ago
-14%
Artelo Biosciences shares are trading higher after the company received written scientific advice from the UK MHRA affirming the proposed design for its Phase 1 trial of ART12.11.
